{"id":79911,"date":"2020-10-09T10:07:45","date_gmt":"2020-10-09T14:07:45","guid":{"rendered":"https:\/\/decisionresourcesgroup.com\/?p=79911"},"modified":"2024-07-05T16:45:00","modified_gmt":"2024-07-05T16:45:00","slug":"acute-respiratory-distress-syndrome-doubles-u-s-covid-19","status":"publish","type":"post","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/blog\/acute-respiratory-distress-syndrome-doubles-u-s-covid-19\/","title":{"rendered":"Acute respiratory distress syndrome doubles in U.S. during COVID-19"},"content":{"rendered":"

\"\"<\/a><\/p>\n

Acute respiratory distress syndrome (ARDS), one of the most severe consequences of COVID-19<\/a>, is often fatal and may develop in COVID-19 patients already in a critically ill state.<\/p>\n

To examine the impact of the COVID-19 pandemic on ARDS risk, we analysed the number of patients in the United States making medical claims for ARDS between two time periods: April to May 2019 (before the Sars-CoV2 virus had been detected), and April to May 2020 (during the peak of mortality due to COVID-19.<\/p>\n

The figures are startling, but as expected: between the two time periods, the number of people claiming for ARDS more than doubled – from 18,000 in 2019 to 37,000 in 2020. The United States has been hit badly with COVID-19-associated mortality, and so this increase may not be seen to the same extent in other countries. But if ARDS tracks COVID-19 mortality, we could see hundreds of thousands more cases of COVID-19-associated ARDS before the pandemic is over.<\/p>\n","protected":false},"excerpt":{"rendered":"

Acute respiratory distress syndrome (ARDS), one of the most severe consequences of COVID-19, is often fatal and may develop in COVID-19 patients already in a critically ill state. To examine…<\/p>\n","protected":false},"author":33,"featured_media":266566,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_links_to":"","_links_to_type":0,"footnotes":""},"categories":[19,21],"tags":[280],"class_list":["post-79911","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biopharma","category-life-sciences-healthcare","tag-covid-19","clarivate-product-biopharma"],"acf":[],"lang":"en","translations":{"en":79911},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/79911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/comments?post=79911"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/79911\/revisions"}],"predecessor-version":[{"id":266317,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/79911\/revisions\/266317"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media\/266566"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=79911"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/categories?post=79911"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/tags?post=79911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}